Notable Facts
→Chief Accounting Officer at NASDAQ-listed Liquidia Corporation (LQDA) as of July 2025
→Previously served as SVP Finance and Controller at Liquidia since January 2021
→20+ years of experience in accounting and financial planning
→Certified Public Accountant licensed in New York
→Former Deloitte auditor with M&A transaction services experience
→Has worked at multiple biotech companies including Aerami Therapeutics and Aralez Pharmaceuticals
→$425,000 annual base salary with $300,000 RSU grant upon CAO appointment
→Regular insider trading activity reported in financial media